LadRx (STU:CX5) E10: €-4.85 (As of Mar. 2025)


STU:CX5 LadRx Corp STU:CX5
40 GF Score
Price €0.06
View Full Analysis

What is LadRx E10?

LadRx STU:CX5 40 E10 is €-4.85 as of Mar. 2025. GuruFocus rates STU:CX5 with a GF Score™ of 40/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

LadRx's adjusted earnings per share data for the three months ended in Mar. 2025 was €-1.341. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-4.85 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-30), LadRx's current stock price is €0.056. LadRx's E10 for the quarter that ended in Mar. 2025 was €-4.85. LadRx's Shiller PE Ratio of today is .


LadRx  (STU:CX5) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


LadRx E10 Related Terms


LadRx E10 Historical Data

* Premium members only.

The historical data trend for LadRx's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LadRx E10 Chart

LadRx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.94 -2.79 -2.31 -8.62 -5.44

LadRx Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.86 -4.11 -5.67 -5.44 -4.85

STU:CX5 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, LadRx's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LadRx Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LadRx's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where LadRx's Shiller PE Ratio falls into.


STU:CX5
40GF Score
LadRx Corp STU:CX5
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LadRx E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, LadRx's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-1.341/319.7990*319.7990
=-1.341

Current CPI (Mar. 2025) = 319.7990.

LadRx Quarterly Data

per share eps CPI Adj_EPS
201506 -112.266 238.638 -150.448
201509 -58.806 237.945 -79.035
201512 -192.781 236.525 -260.654
201603 -102.372 238.132 -137.480
201606 -144.180 241.018 -191.308
201609 -71.280 241.428 -94.419
201612 -31.284 241.432 -41.439
201703 -56.100 243.801 -73.588
201706 -53.400 244.955 -69.716
201709 -15.941 246.819 -20.654
201712 -10.985 246.524 -14.250
201803 -12.165 249.554 -15.589
201806 -8.560 251.989 -10.863
201809 -8.570 252.439 -10.857
201812 -6.153 251.233 -7.832
201903 -3.540 254.202 -4.453
201906 -3.540 256.143 -4.420
201909 -3.632 256.759 -4.524
201912 -8.100 256.974 -10.080
202003 -2.715 258.115 -3.364
202006 -3.552 257.797 -4.406
202009 -6.792 260.280 -8.345
202012 -2.466 260.474 -3.028
202103 -3.360 264.877 -4.057
202106 -2.490 271.696 -2.931
202109 -3.400 274.310 -3.964
202112 -21.240 278.802 -24.363
202203 -3.632 287.504 -4.040
202206 -2.129 296.311 -2.298
202209 -2.808 296.808 -3.026
202212 8.166 296.797 8.799
202303 -0.028 301.836 -0.030
202306 5.953 305.109 6.240
202309 -1.546 307.789 -1.606
202312 -1.751 306.746 -1.826
202403 0.350 312.332 0.358
202406 -2.406 314.175 -2.449
202409 -1.505 315.301 -1.526
202412 0.640 315.605 0.649
202503 -1.341 319.799 -1.341

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-4.85 mean?
LadRx (STU:CX5) has a E10 of €-4.85 as of Mar. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on LadRx and its competitors.
Is LadRx's E10 too high?
LadRx's current E10 is €-4.85. Overall, LadRx has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does LadRx's E10 compare to VRTX and REGN?
LadRx's E10 of €-4.85 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on LadRx and its competitors. LadRx's current E10 is €-4.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LadRx stock overvalued right now?
LadRx (STU:CX5) has a current E10 of €-4.85. The current E10 is €-4.85. LadRx's overall GF Score™ is 40/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For LadRx (STU:CX5), the current E10 is €-4.85 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LadRx Business Description

Address 11726 San Vicente Boulevard, Suite 650, Los Angeles, CA, USA, 90049
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.
40GF Score

Get the complete analysis for STU:CX5

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price